Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739989014 | Erythromycin and zinc acetate only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739990017 | Product containing only erythromycin and zinc acetate in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erythromycin and zinc acetate only product in cutaneous dose form | Is a | Product containing erythromycin and zinc acetate in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Erythromycin and zinc acetate only product in cutaneous dose form | Has active ingredient | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Erythromycin and zinc acetate only product in cutaneous dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Erythromycin and zinc acetate only product in cutaneous dose form | Has active ingredient | Zinc acetate (substance) | true | Inferred relationship | Some | 2 | |
| Erythromycin and zinc acetate only product in cutaneous dose form | Is a | Product containing only erythromycin and zinc acetate (medicinal product) | true | Inferred relationship | Some | ||
| Erythromycin and zinc acetate only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Erythromycin and zinc acetate only product in cutaneous dose form | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution | Is a | True | Erythromycin and zinc acetate only product in cutaneous dose form | Inferred relationship | Some |
Reference Sets
FHIR